ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HLA antibodies"

  • 2015 American Transplant Congress

    The Effect of Preformed and De Novo Donor-Specific Antibodies (DSA) in Acute Rejection (AR) After Liver Transplantation (LTX)

    M. Koch,1 M. Runnebaum,1 M. Goebel,2 H. Thude,1 M. Sterneck,1 M. Marget,2 B. Nashan.1

    1Hepatobiliary Surgery and Transplantation, University Medical Centre, Hamburg, Germany; 2HLA-Laboratory, University Medical Centre, Hamburg, Germany.

    BACKGROUND: The role of preformed and den novo formed DSA in LTX is not fully revealed. The aim of our study was to determine if…
  • 2015 American Transplant Congress

    Interference of Therapeutic Antibodies Used in Desensitization Protocols On Lymphocytotoxicity Crossmatch Results

    D. Milongo,1,3 G. Vieu,2,4,3 S. Blavy,2,4 A. Del Bello,1,3 F. Sallusto,5 L. Rostaing,1,3 N. Kamar,1,3 N. Congy-Jolivet.2,4,3

    1Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France; 2Laboratoire d'Immunologie, CHU de Toulouse, Toulouse, France; 3Université Toulouse III Paul-Sabatier, Toulouse, France; 4Laboratoire d'Immunogénétique Moléculaire, EA 3034, Université Toulouse III Paul-Sabatier, Toulouse, France; 5Department of Urology, CHU Rangueil, Toulouse, France.

    Background: Therapeutic antibodies used to desensitize patients awaiting a human leukocyte antigen (HLA) or ABO-mismatched graft are suspected to interfere with the lymphocytotoxicity crossmatch (LCT-XM)…
  • 2015 American Transplant Congress

    Part II: Rates and Determinants of Progression for De Novo Donor-Specific Antibody Mediated Kidney Allograft Injury

    C. Wiebe,1,2 I. Gibson,3 D. Pochinco,2 P. Birk,4 T. Blydt-Hansen,4 J. Ho,1,5 M. Karpinski,1 A. Goldberg,4 L. Storsley,1 D. Rush,1 P. Nickerson.1,2,5

    1Medicine, University of Manitoba, Winnipeg, MB, Canada; 2Immunogenetics, Diagnostic Services of Manitoba, Winnipeg, MB, Canada; 3Pathology, University of Manitoba, Winnipeg, MB, Canada; 4Pediatric and Child Health, University of Manitoba, Winnipeg, MB, Canada; 5Immunology, University of Manitoba, Winnipeg, MB, Canada.

    The development of de novo donor-specific antibody (dnDSA) is an independent predictor of allograft loss in renal transplantation. Rates and determinants of clinical pathologic progression…
  • 2015 American Transplant Congress

    Antibody Response Following Influenza Vaccination in Renal Transplant Recipients

    M. Mujtaba, B. Book, A. Sharfuddin, A. Khalil, S. Vaishnav, E. Wiebke, M. Yaqub, D. Mishler, T. Taber.

    Indiana University School of Medicne-IU Health, Indianapolis, IN.

    Purpose: Following the recommended consensus guidelines of ATC for vaccination, at our institution we recommend annual vaccination for influenza + H1N1 (Flu) for renal transplant…
  • 2015 American Transplant Congress

    Clinical Outcome of Patients With De Novo C1q Binding Donor-Specific HLA Antibodies After Renal Transplantation

    J. Bamoulid,1 A. Roodenburg,2 O. Staeck,1 C. Schoenemann,2 N. Lachmann,2 K. Budde.1

    1Nephrology, Charite Hospital-University of Medicine, Berlin, Germany; 2HLA Laboratory, Charite Hospital-University of Medicine, Berlin, Germany.

    A. Not all de novo donor-specific HLA antibodies (dnDSA) are causing immediate graft loss. The importance of complement-binding DSA was recently shown with a commercial…
  • 2015 American Transplant Congress

    Deceased Donor HLA Antibody Incompatible Renal Transplantation Without Antibody Removal: High Incidence of Acute Rejection Reduced By T-Cell Depleting Induction Therapy

    E. Jolly,1 C. Taylor,2 H. Morgan,2 S. Peacock,2 M. Clatworthy,1 N. Torpey.1

    1Division of Renal Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom; 2Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

    Aims: Screening for HLA-specific antibodies (Ab) is routine for patients on kidney transplant waiting lists, and HLA antigens to which a patient has detectable Ab…
  • 2015 American Transplant Congress

    Impact of Donor Specific Antibodies in the Older Kidney Transplant Recipient

    S. Patel, J. Loucks-DeVos, R. Knight, S. Kuten, L. Gaber, A. Gaber.

    Houston Methodist Hospital, Houston.

    Recent evidence suggests that renal transplant recipients (RTR) with both rejection and donor specific antibodies (DSA) are at high risk of graft loss. Concurrently, the…
  • 2015 American Transplant Congress

    Cognate Events in Antibody- Vs. T Cell-Mediated Rejection: A Molecular Perspective

    M. Parkes,1 P. Halloran,1 L. Hidalgo.2

    1Department of Medicine, University of Alberta, Edmonton, AB, Canada; 2Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, AB, Canada.

    AIM: The cognate event in antibody-mediated rejection (ABMR) is NK cell FcR engagement; T cell mediated rejection (TCMR) uses TCR engagement. Understanding the molecular changes…
  • 2015 American Transplant Congress

    Early Antibody Mediated Rejection in HLA Antibody Incompatible Kidney Transplantation – A Treatable Condition Without Heavy Induction Immunosuppression

    S. Daga,1,2 N. Krishnan,1 D. Lowe,3 F. Lam,1 C. Imray,1,2 H. Kashi,1 L. Tan,1 D. Briggs,3 R. Higgins.1,2

    1Renal Department, University Hospital, Coventry, United Kingdom; 2Warwick Medical School, University of Warwick, Coventry, United Kingdom; 3H&I Department, NHSBT, Birmingham, United Kingdom.

    Transplantation across preformed donor specific HLA antibodies (DSA) not only carries a risk of early acute antibody mediated rejection (AMR) and graft loss, but also…
  • 2015 American Transplant Congress

    Distinct Clinical Relevance of BAFF Expression Within the Kidney Graft and Soluble BAFF Serum Levels Indicate Confined Alloimmune Responses Disconnected from the Periphery

    E. Campos,1,2 K. Mine,1 A. Goncalves-Primo,1,2 M. Soares,4 M. Franco,2 J. Medina-Pestana,2,3 H. Tedesco-Silva,3 M. Gerbase-DeLima.1,2

    1Instituto de Imunogenética, AFIP, São Paulo, SP, Brazil; 2Universidade Federal de São Paulo, São Paulo, SP, Brazil; 3Hospital do Rim e Hipertensão- FOR, São Paulo, SP, Brazil; 4Universidade Federal do Parana, Curitiba, PR, Brazil.

    As soluble B-cell activating factor (BAFF) serum levels (sBAFF) may not reflect BAFF concentrations within the graft, what could be related to the inconsistencies in…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences